Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis
Top Cited Papers
- 15 September 2006
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 174 (6) , 659-664
- https://doi.org/10.1164/rccm.200604-520oc
Abstract
Functional studies may be useful to predict survival in idiopathic pulmonary fibrosis (IPF). Various cutoffs of 6-min-walk distance (6MWD) have been suggested to identify patients at a high risk of death. To examine the association between 6MWD and survival in patients with IPF listed for lung transplantation, and to identify sensitive and specific cutoffs for predicting death at 6 mo. We performed a retrospective cohort study of 454 patients classified as having IPF listed for lung transplantation with the United Network for Organ Sharing between June 30, 2004 and July 22, 2005. Lower 6MWD was associated with an increased mortality rate (p value for linear trend < 0.0001). Patients with a walk distance less than 207 m had a more than fourfold greater mortality rate than those with a walk distance of 207 m or more, despite adjustment for demographics, anthropomorphics, FVC % predicted, pulmonary hypertension, and medical comorbidities (adjusted rate ratio, 4.7; 95% confidence interval, 2.5-8.9; p < 0.0001). 6MWD was a significantly better predictor of 6-mo mortality than was FVC % predicted (c-statistic = 0.73 vs. 0.59, respectively; p = 0.02). Lower 6MWD was strongly and independently associated with an increased mortality rate for wait-listed patients classified as having IPF. 6MWD was a better predictor of death at 6 mo than was FVC % predicted.Keywords
This publication has 30 references indexed in Scilit:
- The distance-saturation product predicts mortality in idiopathic pulmonary fibrosisRespiratory Medicine, 2006
- 52: Six minute walk distance (6MWD) predicts waiting list survival in Idiopathic Pulmonary Fibrosis (IPF)The Journal of Heart and Lung Transplantation, 2006
- Increased Myocardial Performance Index Correlates With Biopsy-Proven Rejection in Pediatric Heart Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2006
- High-Dose Acetylcysteine in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2005
- Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantationRespiratory Medicine, 2005
- Registry of the International Society for Heart and Lung Transplantation: Twenty-second Official Adult Lung and Heart-Lung Transplant Report—2005The Journal of Heart and Lung Transplantation, 2005
- The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosisEuropean Respiratory Journal, 2005
- A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2004
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- The epidemiology of interstitial lung diseases.American Journal of Respiratory and Critical Care Medicine, 1994